When treating the skin in patients with CTCL, we aim to minimize the extent of the cutaneous disease and reduce the potential risk of disease progression. Skin-directed therapies can reverse the immunosuppressive effects of malignant T-cells.

In recent years, the pathophysiology of pruritus has been discovered in some conditions, including chronic prurigo and atopic dermatitis. Of particular interest is the type 2 immune response, characterized by T-helper 2 cells and associated cytokines. This immune response seems to play a crucial role in the pathogenesis of these conditions, contributing to the persistence of pruritus over time.

Atopic dermatitis (AD) is a common skin disorder, characterized by a complex and heterogeneous pathogenesis that includes skin barrier dysfunction, allergy/immunology, and pruritus.

(AGA) is a common form of hair loss affecting both men and women. Currently, the most widely used treatment for AGA is topical minoxidil and oral finasteride, both have shown efficacy in promoting hair regrowth.

Climate change is one of the defining health threats of our time. Extreme heat directly interacts with dermatology, as the skin serves as a thermoregulatory organ, and many diseases we care for and medications we use can impact the body’s ability to sweat and cool.

Climate change is one of the defining health threats of our time. Extreme heat directly interacts with dermatology, as the skin serves as a thermoregulatory organ, and many diseases we care for and medications we use can impact the body’s ability to sweat and cool.

Climate change is one of the defining health threats of our time. Extreme heat directly interacts with dermatology, as the skin serves as a thermoregulatory organ, and many diseases we care for and medications we use can impact the body’s ability to sweat and cool.